Elicio Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 09, 2023 at 04:41 pm EST
Elicio Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 10.66 million compared to USD 7.2 million a year ago. Basic loss per share from continuing operations was USD 1.27 compared to USD 22.67 a year ago.
For the nine months, net loss was USD 26.25 million compared to USD 21.56 million a year ago. Basic loss per share from continuing operations was USD 3.18 compared to USD 68.52 a year ago.